Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Gorilla and King Portfolio Candidates -- Ignore unavailable to you. Want to Upgrade?

To: Michael P. Michaud who wrote (54686)	3/31/2004 11:32:50 AM
From: DaiTN	Read Replies (1) \| Respond to of 54805

DIO: Begins Offering to Shareholders as of 8/29/03 [delayed] 09:13 a.m. 03/04/2004 Provided by Ridgeland, MS, MAR 04, 2004 (EventX/Knobias.com via COMTEX) -- Diomed Holdings, Inc. (DIO) has commenced an offering to those persons who held shares of its common stock on 8/29/03. The offering is for up to 29,711,749 shares of DIO common stock. DIO stockholders as of 8/29/03 may purchase from DIO one share of common stock for each share of common stock held on 8/29, at a purchase price of 10c per share . The offering period will be 45 days, commencing on 3/3/04 and ending at 5:00 pm EST on 4/16/04, unless DIO elects to extend the offering period. GET KNOBIAS IN REAL-TIME: Delivery of this proprietary Knobias alert has been delayed by at least 10 minutes. To get all Knobias alerts in real-time daily, visit knobias.com ABOUT KNOBIAS: Knobias is a premier financial information provider of trading and investing data covering all U.S. equities for investors and security professionals. Knobias is best described by its three major components: Real-time desktop applications providing quotes, charts, level 2, analysis etc.; Knobias RAiDAR providing thousands of real-time news stories, alerts and documents daily; Knobias fundamentals providing a comprehensive database of fundamental research information. Knobias.com, LLC 601-978-3399 601-978-3675 info@knobias.com www.knobias.com/cmtx Copyright 2004 Knobias.com, LLC, All rights reserved.

To: Michael P. Michaud who wrote (54686)	4/5/2004 7:46:12 AM
From: Pogeu Mahone	Read Replies (2) \| Respond to of 54805

can`t you find something better to invest in?:) Press Release Source: Diomed, Inc. Diomed Initiates Patent Infringement Litigation Against Total Vein Solutions, LLC. Monday April 5, 7:00 am ET ANDOVER, Mass.--(BUSINESS WIRE)--April 5, 2004--Diomed, Inc., a subsidiary of Diomed Holdings, Inc. (AMEX: DIO - News), today announced that it has commenced legal action in the United States Federal District Court for the District of Massachusetts against Total Vein Solutions, LLC., of Houston, Texas, seeking injunctive relief and damages for infringement of Diomed's United States Patent Number 6,398,777 covering the endovascular laser treatment of varicose veins. Earlier this year, Diomed filed patent infringement actions against AngioDynamics, Inc., a subsidiary of E-Z-EM, Inc., and Vascular Solutions, Inc. Diomed is a leading developer and marketer of minimally invasive medical technologies, including EVLT® for the laser treatment of varicose veins, and acquired exclusive rights to the patent from the five inventors of the procedure in September 2003. "Total Vein Solutions has ignored Diomed's patent rights in the field of endovenous laser treatment of venous incompetence and is openly promoting and marketing laser fibers and associated procedure kit components without a license from us", stated James Wylie, President and Chief Executive Officer of Diomed Holdings, Inc.